史赛克Stryker Corporation（SYK）2025年第二季度业绩报告「NYSE」（英文版）（10页）.pdf

1、 1 1941 Stryker Way Portage,MI 49002 Press release Number:25-19 Date:July 31,2025 Stryker reports second quarter 2025 operating results Portage,Michigan July 31,2025 Stryker(NYSE:SYK)reported operating results for the second quarter of 2025:Second Quarter Results Reported net sales increased 11.1%to

2、$6.0 billion Organic net sales increased 10.2%Reported operating income margin of 18.5%Adjusted operating income margin(1)increased 110 bps to 25.7%Reported EPS increased 7.0%to$2.29 Adjusted EPS(1)increased 11.4%to$3.13 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Con

3、stant Currency Acquisitions/Divestitures Organic MedSurg and Neurotechnology 17.3%0.6%16.7%5.7%11.0%Orthopaedics 2.0 0.9 1.1 (7.9)9.0 Total 11.1%0.8%10.3%0.1%10.2%“We again delivered double-digit sales and adjusted earnings per share growth in the second quarter,”said Kevin A.Lobo,Chair and CEO.“Our

4、 strong sales and earnings power reflect demand for our products,our durable innovation pipeline and ongoing operational execution.”Sales Analysis Consolidated net sales of$6.0 billion increased 11.1%in the quarter and 10.3%in constant currency.Organic net sales increased 10.2%in the quarter includi

5、ng 9.7%from increased unit volume and 0.5%from higher prices.MedSurg and Neurotechnology net sales of$3.8 billion increased 17.3%in the quarter and 16.7%in constant currency.Organic net sales increased 11.0%in the quarter including 10.2%from increased unit volume and 0.8%from higher prices.Orthopaed

6、ics net sales of$2.2 billion increased 2.0%in the quarter and 1.1%in constant currency.Excluding the impact of the divested Spinal implant business,Orthopaedics growth increased 10.7%and 9.7%in constant currency.Organic net sales increased 9.0%in the quarter including 9.0%from increased unit volume.